SciELO - Scientific Electronic Library Online

 
vol.128 número11Alteraciones de la motricidad del cuerpo del esófago en pacientes con enfermedad por reflujo gastroesofágico sin reflujo patológico en la monitorización de pH de 24 hMesenteritis retráctil: Comunicación de cuatro casos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

CASTRO G, Pablo et al. Humoral rejection in heart transplantation: Report of two cases. Rev. méd. Chile [online]. 2000, vol.128, n.11, pp.1245-1249. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872000001100009.

Heart transplantation is a therapeutic alternative for selected patients with refractory heart failure. Acute allograft rejection is one of the main causes of early death after transplantation. The cellular rejection is characterized by cellular infiltrates with or without miocyte necrosis. However, some patients develop left ventricular dysfunction due to rejection without evidence of cellular infiltration. In these patients, the rejection is mediated by antibodies and complement. Humoral rejection is a relative rare but potentially fatal form of acute allograft rejection. We report two patients with left ventricular dysfunction secondary to humoral rejection, shortly after cardiac transplantation. Both patients were treated with methylprednisolone, and azathioprine was substituted by cyclophosphamide. One patient underwent plasmapheresis. The clinical outcome was satisfactory and the left ventricular function returned to normal in both cases. The diagnostic and therapeutic strategies for the management of humoral rejection are reviewed (Rev Méd Chile 2000; 128: 1245-49)

Palavras-chave : Azathioprine; Heart transplantation; Methylprednisolone; Transplantation; isogeneic; Transplant rejection.

        · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons